DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine
DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine is a paper indexed in PICO Portal from OpenAlex.
How many citations does DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine have?
DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine has 213 citations in the OpenAlex counts PICO Portal stores.
When was DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine published?
DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine has 2018 year in the PICO Portal index.
What is the open-access status of DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine?
DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine has bronze oa status in the PICO Portal index.
What is the DOI of DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine?
The DOI for DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine is on the source record.
What is the PMID of DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine?
The PMID for DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine is on the source record.
What is the OpenAlex record for DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine?
The OpenAlex for DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine is on the source record.